Anda di halaman 1dari 27

Case: 18-1197 Document: 103 Page: 1 Filed: 08/19/2019

No. 2018-1197

IN THE

United States Court of Appeals


FOR THE FEDERAL CIRCUIT
VIRNETX INC., LEIDOS, INC.,
Plaintiffs-Appellees,
V.

CISCO SYSTEMS, INC.,


Defendant,
APPLE INC.,
Defendant-Appellant.

On Appeal from the United States District Court for the Eastern District of Texas
Case No. 6:10-cv-00417-RWS, Judge Robert Schroeder, III

OPPOSITION OF VIRNETX INC. AND LEIDOS, INC. TO


APPLE INC.’S MOTION TO STAY THE MANDATE

Bradley Wayne Caldwell Jeffrey A. Lamken


Jason Dodd Cassady Counsel of Record
John Austin Curry Michael G. Pattillo, Jr.
CALDWELL CASSADY & CURRY MOLOLAMKEN LLP
2101 Cedar Springs Road The Watergate, Suite 660
Suite 1000 600 New Hampshire Avenue, N.W.
Dallas, TX 75201 Washington, D.C. 20037
(214) 888-4848 (telephone) (202) 556-2000 (telephone)
(214) 888-4849 (fax) (202) 556-2001 (fax)
jlamken@mololamken.com
Counsel for VirnetX Inc.
(Additional Counsel Listed on Inside Cover)
Case: 18-1197 Document: 103 Page: 2 Filed: 08/19/2019

(
Rayiner I. Hashem Donald Urrabazo
James A. Barta URRABAZO LAW, P.C.
MOLOLAMKEN LLP 2029 Century Park East
The Watergate, Suite 660 Suite 1400
600 New Hampshire Ave., N.W. Los Angeles, CA 90067
Washington, D.C. 20037 (310) 388-9099 (telephone)
(202) 556-2000 (telephone) (310) 388-9088 (fax)
(202) 556-2001 (fax)
Counsel for Leidos, Inc.
Allison M. Gorsuch
MOLOLAMKEN LLP
300 N. LaSalle St.
Chicago, IL 60654
(312) 450-6700 (telephone)
(312) 450-6701 (fax)

Counsel for VirnetX Inc.


Case: 18-1197 Document: 103 Page: 3 Filed: 08/19/2019
FORM 9. Certificate of Interest Form 9
Rev. 10/17
UNITED STATES COURT OF APPEALS FOR THE FEDERAL CIRCUIT
VirnetX Inc. v. Cisco Systems, Inc.
Case No. 18-1197
CERTIFICATE OF INTEREST

Counsel for the:


… (petitioner) … (appellant) … (respondent) … (appellee) … (amicus) … (name of party)

VirnetX Inc.
certifies the following (use “None” if applicable; use extra sheets if necessary):

2. Name of Real Party in interest 3. Parent corporations and


1. Full Name of Party (Please only include any real party publicly held companies
Represented by me in interest NOT identified in that own 10% or more of
Question 3) represented by me is: stock in the party
VirnetX Inc. VirnetX Inc. VirnetX Holding Corp.

4. The names of all law firms and the partners or associates that appeared for the party or amicus now
represented by me in the trial court or agency or are expected to appear in this court (and who have not
or will not enter an appearance in this case) are:
Avanci LLC: Luke F. McLeroy
Caldwell Cassady & Curry PC: Bradley W. Caldwell, Christopher S. Stewart, Daniel R. Pearson, Hamad M. Hamad, Jason D. Cassady, John A.
Curry, John F. Summers, Justin T. Nemunaitis.
Fish & Richardson PC: Andrew T. Gorham.
Gruber Hail Johansen Shank LLP: Jason S. McManis.
McKool Smith: Seth R. Hasenour, Trent E. Campione, Douglas A. Cawley, Mitchell R. Sibley, Rosemary T. Snider, Ryan A. Hargrave, Stacie G.
McNulty, Christopher L. Limpus, Samuel F. Baxter.
Parker, Bunt & Ainsworth PC: Ramzi R. Khazen, Robert C. Bunt, Robert M. Parker.
Ward, Smith & Hill PLLC: Thomas J. Ward, Jr., Claire A. Henry.
MoloLamken LLP: Jeffrey A. Lamken; Michael G. Pattillo, Jr.; Rayiner I. Hashem; James A. Barta; Allison M. Gorsuch
Case: 18-1197 Document: 103 Page: 4 Filed: 08/19/2019
FORM 9. Certificate of Interest Form 9
Rev. 10/17

5. The title and number of any case known to counsel to be pending in this or any other court or agency
that will directly affect or be directly affected by this court’s decision in the pending appeal. See Fed. Cir.
R. 47. 4(a)(5) and 47.5(b). (The parties should attach continuation pages as necessary).
VirnetX Inc. v. Apple Inc., Nos. 17-1591, -1592, -1593 (Fed. Cir.)
VirnetX Inc. v. The Mangrove Partners Master Fund, Ltd., Nos. 17-1368, -1383 (Fed. Cir.)
VirnetX Inc. v. Iancu, Nos. 17-2593, -2594 (Fed. Cir.)
VirnetX Inc. v. Cisco Sys., Inc., No. 18-1751 (Fed. Cir.)
VirnetX Inc. v. Apple Inc., No. 19-1050 (Fed. Cir.)
Control No. 95/001,679 (USPTO)
Control No. 95/001,682 (USPTO)
Control No. 95/001,697 (USPTO)
Control No. 95/001,714 (USPTO)

8/19/2019 /s/ Jeffrey A. Lamken


Date Signature of counsel

Please Note: All questions must be answered Jeffrey A. Lamken


Printed name of counsel

cc: All counsel of record

Reset Fields
Case: 18-1197 Document: 103 Page: 5 Filed: 08/19/2019
FORM 9. Certificate of Interest Form 9
Rev. 10/17
UNITED STATES COURT OF APPEALS FOR THE FEDERAL CIRCUIT
VirnetX Inc. v. Cisco Systems, Inc.
Case No. 18-1197
CERTIFICATE OF INTEREST

Counsel for the:


… (petitioner) … (appellant) … (respondent) … (appellee) … (amicus) … (name of party)

Leidos, Inc.
certifies the following (use “None” if applicable; use extra sheets if necessary):

2. Name of Real Party in interest 3. Parent corporations and


1. Full Name of Party (Please only include any real party publicly held companies
Represented by me in interest NOT identified in that own 10% or more of
Question 3) represented by me is: stock in the party
Leidos, Inc. Leidos, Inc. Leidos Holdings, Inc.

4. The names of all law firms and the partners or associates that appeared for the party or amicus now
represented by me in the trial court or agency or are expected to appear in this court (and who have not
or will not enter an appearance in this case) are:
Urrabazo Law, P.C.: Donald Urrabazo
MT2 Law Group: Andy Tindel
Case: 18-1197 Document: 103 Page: 6 Filed: 08/19/2019
FORM 9. Certificate of Interest Form 9
Rev. 10/17

5. The title and number of any case known to counsel to be pending in this or any other court or agency
that will directly affect or be directly affected by this court’s decision in the pending appeal. See Fed. Cir.
R. 47. 4(a)(5) and 47.5(b). (The parties should attach continuation pages as necessary).
VirnetX Inc. v. Apple Inc., Nos. 17-1591, -1592, -1593 (Fed. Cir.)
VirnetX Inc. v. The Mangrove Partners Master Fund, Ltd., Nos. 17-1368, -1383 (Fed. Cir.)
VirnetX Inc. v. Iancu, Nos. 17-2593, -2594 (Fed. Cir.)
VirnetX Inc. v. Cisco Sys., Inc., No. 18-1751 (Fed. Cir.)
VirnetX Inc. v. Apple Inc., No. 19-1050 (Fed. Cir.)
Control No. 95/001,679 (USPTO)
Control No. 95/001,682 (USPTO)
Control No. 95/001,697 (USPTO)
Control No. 95/001,714 (USPTO)

8/19/2019 /s/ Donald Urrabazo


Date Signature of counsel

Please Note: All questions must be answered Donald Urrabazo


Printed name of counsel

cc: All counsel of record

Reset Fields
Case: 18-1197 Document: 103 Page: 7 Filed: 08/19/2019

TABLE OF CONTENTS

Page

BACKGROUND .......................................................................................................2

I. Three Trials Result in Three Verdicts for VirnetX—and Decisions


of This Court Upholding Validity, Damages, and Infringement.....................2

A. Proceedings Leading to This Appeal ...................................................2

B. Apple Repeatedly Seeks To Stay or Stall Court Proceedings


Pending Unsuccessful Efforts To Cancel Claims Through
the PTO ................................................................................................3

C. This Court Summarily Affirms—But Apple Seeks Rehearing,


Rehearing En Banc, and Further Delays .............................................4

D. The Court Denies Rehearing—and Rejects Apple’s Collateral


Estoppel Arguments.............................................................................6

II. The Current Motions ........................................................................................7

ARGUMENT .............................................................................................................8

I. Apple’s Request To Stay the Mandate and These Proceedings


Indefinitely Pending PTO Proceedings Should Be Denied .............................8

II. Apple Has Failed To Justify a Stay of the Mandate Pending


Certiorari Proceedings ...................................................................................10

III. Apple’s Request for a Stay of the Mandate Pending Resolution


of Its Motion To Vacate Denial of Rehearing and for a Second
Rehearing Petition Is Unnecessary ................................................................14

CONCLUSION ........................................................................................................15

i
Case: 18-1197 Document: 103 Page: 8 Filed: 08/19/2019

TABLE OF AUTHORITIES
Page(s)

CASES
Bettcher Indus., Inc. v. Bunzl USA, Inc.,
661 F.3d 629 (Fed. Cir. 2011) ............................................................................ 10

Nara v. Frank,
494 F.3d 1132 (3d Cir. 2007) ............................................................................. 13

Philip Morris USA Inc. v. Scott,


131 S. Ct. 1 (2010) .............................................................................................. 11

Rector v. Lipscomb,
141 U.S. 557 (1891) ............................................................................................ 12

Teva Pharms. USA, Inc. v. Sandoz, Inc.,


134 S. Ct. 1621 (2014) ..................................................................................11, 13

VirnetX Inc. v. Cisco Sys., Inc.,


748 F. App’x 332 (Fed. Cir. 2019) ................................................................... 4, 9

VirnetX, Inc. v. Cisco Sys., Inc.,


767 F.3d 1308 (Fed. Cir. 2014) ...................................................................passim

STATUTES & RULES


35 U.S.C. § 282(b)(2) ............................................................................................... 10

35 U.S.C. § 282(b)(3) ............................................................................................... 10

Fed. R. App. P. 41(a) ............................................................................................... 15

Fed. R. App. P. 41(b) ................................................................................................. 2

Fed. R. App. P. 41(d)(1).................................................................................2, 11, 12

Fed. Cir. R. 35(b)(2)................................................................................................. 14

Fed. Cir. R. 40(a)(4) ................................................................................................. 14

Fed. Cir. R. 41 .......................................................................................................... 11

ii
Case: 18-1197 Document: 103 Page: 9 Filed: 08/19/2019

OTHER AUTHORITIES
Charles Alan Wright et al., Fed. Prac. & Proc. § 3536
(3d ed.) ................................................................................................................ 12

Shapiro et al., Supreme Court Practice


(10th ed. 2013) .................................................................................................... 12

iii
Case: 18-1197 Document: 103 Page: 10 Filed: 08/19/2019

Among other things, Apple seeks an indefinite stay of the mandate until

Apple finishes litigating its seriatim PTO challenges, not merely on remand at the

PTO but until the completion of potential appeals before this Court. Apple has

repeatedly sought such indefinite delays before, seeking to further stall progress in

this already 9-year-old lawsuit, despite this Court having upheld validity years ago

and despite Apple failing to raise any validity issues in this appeal. This Court and

the district court have repeatedly rejected such bids for delay. The Court should

reject this one as well. Apple, in effect, seeks to give PTO proceedings absolute

priority over Article III court determinations. No rule of law supports that result.

Apple’s request for a stay of the mandate pending the filing of a petition for

a writ of certiorari lacks merit as well. Apple does not meet the stringent criteria

required for such a stay. Apple posits concern that, absent a stay, VirnetX may

argue that issuance of the mandate somehow forecloses Supreme Court review

under Fresenius USA, Inc. v. Baxter International Inc., 721 F.3d 1330 (Fed. Cir.

2013). But Apple never explains that argument, much less why it believes VirnetX

will make it. Apple cannot invent spurious arguments, impute them to VirnetX,

and then cite them as grounds for a stay.

Finally, while Apple asks the Court to stay the mandate until it decides

Apple’s motion to vacate the denial of rehearing, and for leave to file a successive

rehearing petition, that relief is not necessary. Apple’s motion to stay the mandate,
Case: 18-1197 Document: 103 Page: 11 Filed: 08/19/2019

by itself, prevents the mandate’s issuance absent contrary order. Fed. R. App. P.

41(b). Accordingly, this Court can act first on Apple’s motion to vacate the denial

of rehearing, and for leave to file a successive rehearing petition, without staying

the mandate in the interim. If the Court denies that motion—it lacks merit—it can

simultaneously deny the motion to stay the mandate as well.1

BACKGROUND
VirnetX filed this patent infringement suit against Apple nine years ago, in

August 2010.

I. THREE TRIALS RESULT IN THREE VERDICTS FOR VIRNETX—AND


DECISIONS OF THIS COURT UPHOLDING VALIDITY, DAMAGES, AND
INFRINGEMENT

A. Proceedings Leading to This Appeal


In November 2012, the jury found that Apple’s VPN on Demand and

FaceTime products infringe claims of VirnetX’s ’135, ’151, ’504, and ’211

Patents. The jury found all four patents not invalid, and awarded damages for both

VPN on Demand and FaceTime infringement. On appeal, this Court affirmed the

finding of validity, but vacated the infringement verdict as to FaceTime and

remanded for a new trial on damages. VirnetX, Inc. v. Cisco Sys., Inc., 767 F.3d

1308, 1313-14 (Fed. Cir. 2014) (“VirnetX I ”).

1
If the Court grants Apple’s motion to file a successive rehearing petition, the
motion to stay the mandate would be moot. An otherwise timely petition for
rehearing stays the mandate as well. Fed. R. Civ. P. 41(b).
2
Case: 18-1197 Document: 103 Page: 12 Filed: 08/19/2019

After remand, another jury returned a verdict in favor of VirnetX, which the

district court set aside. Appx12. Following a third trial in September 2016, yet

another jury found that FaceTime infringed claims of the ’504 and ’211 Patents.

Appx14. It also awarded damages for Apple’s infringement as to both VPN on

Demand and FaceTime. Id. Apple then filed this appeal, Case No. 18-1197.

B. Apple Repeatedly Seeks To Stay or Stall Court Proceedings


Pending Unsuccessful Efforts To Cancel Claims Through the PTO

In the meantime, Apple and associated parties filed multiple proceedings

seeking to invalidate VirnetX’s patents at the PTO. Eventually, VirnetX appealed

several PTO decisions that had found certain claims asserted in this case to be

unpatentable. In Case No. 17-1591, Apple had challenged all asserted claims of

the ’504 and ’211 Patents, and Cisco had challenged all asserted claims of the ʼ211

Patent. In Case No. 18-1751, Cisco had challenged all asserted claims of the ’504

Patent. And in Case No. 17-1368, an entity called Mangrove Partners had

challenged claims of the ’135 and ’151 Patents.

Apple’s Stay Requests Before the Trial Court. Apple first sought to stay this

district court case pending PTO proceedings in August 31, 2012, more than two

years after it was filed, and just two months before the first trial. Dkt. 477. Apple

then filed three more motions to stay proceedings in the district court. It continued

filing repetitive stay motions even after this Court affirmed the patents’ validity in

3
Case: 18-1197 Document: 103 Page: 13 Filed: 08/19/2019

VirnetX I, leading the district court to enhance damages for such “gamesmanship.”

Appx65.

Apple’s Stay Request Before This Court. At the outset of this appeal (No.

18-1197), Apple asked this Court for a stay pending the appeals of the PTO

proceedings. ECF No. 32. Apple argued that those appeals would soon result in

cancellation of all asserted claims, foreclosing further proceedings in this case (a

prediction that proved false). This Court denied Apple’s stay request. The Court

ordered that this case and the 17-1591 and 17-1368 cases be argued to the same

panel.

C. This Court Summarily Affirms—But Apple Seeks Rehearing,


Rehearing En Banc, and Further Delays
On January 6, 2019, this Court heard argument in this case together with the

17-1591 and 17-1368 cases. At argument, Apple again addressed the potential

implications of the PTO appeals on this case. Tr. 0:37-3:52, 26:00-27:10, 38:40-

41:20. Nine days later, on January 15, 2019, this Court summarily affirmed the

judgment in this case under Rule 36. VirnetX Inc. v. Cisco Sys., Inc., 748 F. App’x

332 (Fed. Cir. 2019) (“VirnetX II ”).

Apple’s Request for Rehearing. Apple sought panel rehearing and rehearing

en banc. ECF No. 78. Apple’s petition addressed damages, jury instructions, and

computation of pre-judgment interest. Apple also used its rehearing petition as a

sixth attempt to seek a stay—asking this Court to hold its decision on rehearing “at

4
Case: 18-1197 Document: 103 Page: 14 Filed: 08/19/2019

least” pending this Court’s decisions in the 17-1591 and 17-1368 cases, and

possibly also the 18-1751 case. ECF No. 78 at 16-18 & n.7.

Apple’s rehearing petition remained pending for nearly five months. During

that time, all of the PTO appeals for which Apple had asked the Court to hold its

rehearing petition were decided. While this Court affirmed the PTO’s findings of

unpatentability as to some asserted claims, it reversed as to others. In case No. 18-

1751, this Court held that the PTAB had failed to explain how the asserted

Lendenmann reference disclosed the “authentication” requirement of claims 5, 12,

and 13 of the ’504 Patent. 18-1751 Op. 7-8. The Court thus remanded for further

proceedings. Id. at 10. In case No. 17-1368, this Court held that substantial

evidence did not support the Board’s finding that claims of the ’151 Patent were

invalid over the asserted Kiuchi reference, and that the Board had erred in its

construction of the relevant claims of the ’135 Patent. 17-1368 Op. 23. The Court

remanded for further proceedings. Id.

Apple’s Supplemental Brief. After this Court’s decision in No. 18-1751

issued, Apple filed a supplemental brief in this case and in the then-still-pending

case No. 17-1591. ECF No. 86; 17-1591 ECF No. 96. Apple urged that “[t]he

preclusive effect” of the decision in No. 18-1751—which affirmed unpatentability

findings as to certain claims of the ’504 Patent—required holding claims of the

’211 Patent invalid in both the (still undecided) case No. 17-1591 and in this

5
Case: 18-1197 Document: 103 Page: 15 Filed: 08/19/2019

(already decided) case as well. ECF No. 86 at 1-2, 9. Apple also urged the Court

to stay its decision on the rehearing petition pending resolution of other PTO

appeals and any follow-on proceedings—effectively a seventh stay motion. Id. at

14. VirnetX filed supplemental briefs in response, explaining why collateral

estoppel did not apply across the patents as Apple claimed. See ECF No. 92; 17-

1591 ECF No. 105.

D. The Court Denies Rehearing—and Rejects Apple’s Collateral


Estoppel Arguments
On August 1, 2019, this Court issued its decision in case No. 17-1591. It

held that pre-AIA 35 U.S.C. § 317(b) required the PTO to terminate Apple’s

reexamination proceedings with respect to claims 1-35 of the ʼ504 Patent and

claims 36-59 if the ʼ211 Patent upon this Court’s affirmance of patent validity in

VirnetX I. 17-1591 Op. 28. The Court affirmed the PTO’s unpatentability findings

as to claims of the ’504 and ’211 Patents that were not subject to § 317(b). Id.

The Court specifically addressed the arguments Apple made in its

supplemental brief “regarding the relationship between this case and other recently

decided matters”—in particular, Apple’s “argu[ment] that collateral estoppel

renders various claims of the ’504 and ’211 patents invalid.” 17-1591 Op. 24 n.15.

The Court found Apple’s argument in part moot (as to claims for which invalidity

was upheld on the merits), and rejected it as “[o]therwise . . . unpersuasive.” Id.

“Apple,” this Court held, “has failed to show why collateral estoppel is appropriate

6
Case: 18-1197 Document: 103 Page: 16 Filed: 08/19/2019

under these circumstances.” Id. That same day, this Court denied Apple’s petition

for rehearing and rehearing en banc in this case. ECF No. 97.

As a result, the damages verdict in this case remains fully supported by

claims found not invalid by this Court. Claim 5 of the ʼ504 Patent supports the

infringement verdict for FaceTime, and several claims of the ʼ135 and ʼ151 Patents

support the infringement verdict for VPN on Demand.

II. THE CURRENT MOTIONS


On August 7, 2019, Apple filed the motion to stay the mandate at issue here.

Concurrently, Apple filed a motion asking the Court to vacate its denial of

rehearing and grant Apple leave to file a second petition for rehearing and

rehearing en banc (or alternatively, yet another supplemental brief). ECF No. 99-

1. Apple urged that rehearing was necessary to consider the supposed collateral

estoppel effects of the Court’s decision with respect to the validity of claim 5 of the

ʼ211 Patent in Case No. 17-1591 on the validity of claim 5 of the ʼ504 Patent in

this case, id. at 14—essentially the same cross-patent theory this Court had already

dismissed as “unpersuasive,” 17-1591 Op. 24 n.15. Apple also made what

amounts to its eighth request for an indefinite stay of this case, asking this Court to

withhold action pending resolution of all PTO proceedings concerning the asserted

patents, including PTO proceedings on remand and appeal. ECF No. 99-1 at 19-

21. VirnetX has filed its opposition to that motion. ECF No. 101.

7
Case: 18-1197 Document: 103 Page: 17 Filed: 08/19/2019

ARGUMENT

I. APPLE’S REQUEST TO STAY THE MANDATE AND THESE PROCEEDINGS


INDEFINITELY PENDING PTO PROCEEDINGS SHOULD BE DENIED
Apple asks that the Court withhold the mandate indefinitely. Mot. 8-9.

Apple asks for that relief in the hope that some future appeal, from some other

PTO proceeding, may achieve what Apple has been unable to achieve thus far—in

nine years of litigation—cancellation of all claims necessary to this judgment. Id.

Apple insists that this case “would have been stayed in its entirety pending the

unpatentability proceedings” if it had been “before most district courts in the

country.” Id. at 9. But Apple never sought this Court’s review of the district

court’s stay rulings.2 And whatever Apple’s hypothetical district court might have

done, this Court has already denied Apple’s request for such open-ended stays

repeatedly—including in Apple’s pre-briefing motion to stay, ECF No. 32; its

petition for panel and en banc rehearing, ECF No. 78; and its supplemental brief in

support of rehearing, ECF No. 86. Nine years, three trials, two appeals, and eight

stay motions into this case, the Court should deny the request yet again (along with

Apple’s request to file a second rehearing petition, ECF No. 99-1 at 19-20).

Apple’s argument that a stay is warranted because PTO proceedings have

the “potential for simplifying proceedings” in this case begs credulity. Mot. 9.

2
Apple shows no abuse of discretion. Apple first sought a stay shortly before the
first trial, two years into the litigation. See pp. 3-4, supra.
8
Case: 18-1197 Document: 103 Page: 18 Filed: 08/19/2019

After nine years of litigation, this Court has upheld validity, upheld infringement,

upheld the damages award, affirmed the judgment below, and denied Apple’s

request for rehearing en banc. VirnetX I, 767 F.3d at 1313-14; 748 F. App’x 332;

ECF No. 97. No issues remain live. There are thus no “proceedings” before the

trial court or this Court that could possibly be “simplified” from awaiting future

PTO proceedings. Apple identifies none.

Apple invokes the non-precedential decision in Prism Technologies LLC v.

Sprint Spectrum LP, 757 F. App’x 980 (Fed. Cir. 2019), for the proposition that

there is a “policy against enforcing an unexecuted judgment of patent liability”

where each of several conditions is satisfied, including where “the patent claims

underlying that judgment have been held invalid by another decision having

sufficient finality for this purpose,” Mot. 8. But that is not the case here. Three

appeals from PTO proceedings have been decided. Yet the judgment remains fully

supported by asserted patent claims. While Apple claims it is not yet “clear

whether [the] judgment rests on a legally sound foundation,” id. at 9, this Court

previously upheld the patents’ validity against Apple’s challenge in this case,

VirnetX I, 767 F.3d at 1313-14. Congress gave Article III courts jurisdiction to

decide issues of patent validity long before it gave the PTO authority to conduct re-

examinations to cancel previously issued patents. See 35 U.S.C. §§ 101-103; id.

§ 282(b)(2) & (3); see also Bettcher Indus., Inc. v. Bunzl USA, Inc., 661 F.3d 629,

9
Case: 18-1197 Document: 103 Page: 19 Filed: 08/19/2019

647 (Fed. Cir. 2011). This Court’s prior decision on validity in this very case is a

“legally sound foundation” for the judgment.

Referring to its “concurrently-filed submissions,” Apple instead argues that

“additional proceedings before this Court and the PTO could . . . lead to a deter-

mination that the asserted claims” are invalid. Mot. 8 (emphasis added). VirnetX

has explained why those arguments fail in its opposition to those submissions, see

ECF No. 101 at 16-19, and will not repeat them here. Suffice to say that Apple’s

arguments—which posit Apple or Cisco first obtaining en banc review of adverse

decisions in separate cases, then prevailing on the merits in the en banc

proceedings, and then prevailing on an “unpersuasive” theory to apply collateral

estoppel across different cases—are far too speculative and attenuated to support

Apple’s request for an indefinite stay of this case.

II. APPLE HAS FAILED TO JUSTIFY A STAY OF THE MANDATE PENDING


CERTIORARI PROCEEDINGS
Apple argues that, “at a minimum,” the Court should stay the mandate

pending disposition of Apple’s forthcoming petition for certiorari in this case.

Mot. 1-2. A stay of the mandate pending disposition of a petition for a writ of

certiorari is “extraordinary relief,” Teva Pharms. USA, Inc. v. Sandoz, Inc., 134 S.

Ct. 1621, 1621 (2014) (Roberts, C.J., in chambers), subject to “a heavy burden” of

justification, Philip Morris USA Inc. v. Scott, 131 S. Ct. 1, 3 (2010) (Scalia, J., in

chambers). To obtain a stay of the mandate pending a petition for a writ of

10
Case: 18-1197 Document: 103 Page: 20 Filed: 08/19/2019

certiorari, a party “must show that the certiorari petition would present a sub-

stantial question and that there is good cause for a stay.” Fed. R. App. P. 41(d)(1).

Apple can show neither.

A. The only “good cause” for a stay pending certiorari posited by Apple

turns out to be non-existent. Apple speculates that “VirnetX may attempt to argue”

that, under this Court’s decision in Fresenius USA, Inc. v. Baxter International

Inc., 721 F.3d 1330 (Fed. Cir. 2013), issuance of this Court’s mandate somehow

precludes Supreme Court review of the judgment in this case, Mot. 12. Apple does

not explain what such an argument might look like. Issuance of this Court’s

mandate merely has the effect of returning jurisdiction from this Court to the trial

court. As this Court’s rules explain, “[t]hat a mandate has issued does not affect

the right to apply to the Supreme Court for a writ of certiorari.” Fed. Cir. R. 41,

Practice Note. As VirnetX explained in related proceedings—citing the leading

treatise on Supreme Court practice—Supreme Court review of a final judgment

opens up the entire case, allowing the Supreme Court to “reach back and correct

errors” even in an earlier court of appeals decision in the same case where the

mandate has already issued. VirnetX Br. 32 in 17-1591 (quoting Shapiro et al.,

Supreme Court Practice 84 (10th ed. 2013)). Apple cannot invent spurious

arguments, impute them to VirnetX, and then use them to justify a stay.

11
Case: 18-1197 Document: 103 Page: 21 Filed: 08/19/2019

Nor, in any event, can Apple explain why a stay of the mandate is necessary

to counteract its made-up theory. Even if VirnetX tried to urge that issuance of

this Court’s mandate somehow rendered the judgment “impervious” to Supreme

Court review, Mot. 12, the Supreme Court itself could reject such an argument. “It

is not in the power of the circuit court to determine the extent and limits of [the

Supreme Court’s] jurisdiction, for that is a matter which [the Supreme Court] must

finally decide for itself.” Rector v. Lipscomb, 141 U.S. 557, 558 (1891); see also

13D Charles Alan Wright et al., Fed. Prac. & Proc. Juris. § 3536 (3d ed.) (courts

always have “[j]urisdiction to determine jurisdiction”). There is no scenario in

which the Supreme Court will be denied the “opportunity to consider” any petition

for a writ of certiorari Apple might file. Mot. 12. For that reason alone, a stay of

the mandate pending certiorari is unwarranted.

B. Apple also fails in its burden to show that the petition would present a

“substantial question” warranting Supreme Court review. Fed. R. App. P.

41(d)(1). Courts have interpreted that standard as requiring movants to show both

“a reasonable probability that the Supreme Court will grant certiorari,” and “a rea-

sonable possibility that at least five Justices would vote to reverse [the court of

appeals’] judgment.” Nara v. Frank, 494 F.3d 1132, 1133 (3d Cir. 2007); see also

Teva, 134 S. Ct. at 1621 (requiring a “reasonable probability” the Supreme Court

will grant certiorari and a “fair prospect” of reversal on the merits). Apple makes

12
Case: 18-1197 Document: 103 Page: 22 Filed: 08/19/2019

no such showing. Apple presents a laundry list of potential issues for certiorari

review and calls them “substantial.” See Mot. 10-11. But merely saying it doesn’t

make it so. Apple provides no legal argument to establish that its purported issues

could conceivably warrant Supreme Court review, because they do not.

Apple’s appeal in this case raised intensely case- and fact-specific issues of

infringement, damages, admissibility of supposedly prejudicial evidence, and the

manner of calculating pre-judgment interest. ECF No. 82 at 5-15. This Court saw

fit to summarily affirm the judgment below in a non-precedential opinion under

Circuit Rule 36. This Court also rejected Apple’s efforts to recast those as issues

having broader importance when it denied Apple’s petition for rehearing en banc.

ECF No. 97. Apple suggests it will also reach back to challenge issues, such as

anticipation, this Court decided in VirnetX I. Mot. 10-11. But those issues are so

insubstantial that Apple did not even seek rehearing, much less petition for certio-

rari, after that decision issued. That Apple may press one or more of its make-

weight arguments in a certiorari petition provides no basis for staying the mandate

in the meantime.

III. APPLE’S REQUEST FOR A STAY OF THE MANDATE PENDING RESOLUTION


OF ITS MOTION TO VACATE DENIAL OF REHEARING AND FOR A SECOND
REHEARING PETITION IS UNNECESSARY
Apple urges that this Court should stay issuance of the mandate “at least

until it considers and disposes of ” Apple’s motion to vacate the Court’s earlier

13
Case: 18-1197 Document: 103 Page: 23 Filed: 08/19/2019

denial of rehearing and for leave to file a successive rehearing petition. Mot. 7.

VirnetX recently filed its opposition brief, explaining why Apple’s request for the

extraordinary relief of a second rehearing petition should be denied. ECF No. 101.

Apple identifies no “points of law or fact overlooked or misapprehended by the

court” in its Rule 36 affirmance of the judgment below as required for panel

rehearing. Fed. Cir. R. 40(a)(4); ECF No. 101 at 9. Nor does Apple’s motion

identify any “precedent-setting questions of exceptional importance” as required to

support rehearing en banc. Fed. Cir. R. 35(b)(2); ECF No. 101 at 10. A fortiori,

Apple’s motion fails to establish the truly exceptional circumstances needed to

justify leave to file a second en banc petition after its first one was denied. Apple

merely attempts to interject into this case a theory of collateral estoppel between

claims of the ʼ211 and ʼ504 Patents that this Court already rejected as

“unpersuasive.” 17-1591 Op. 24 n.15; ECF No. 101 at 11-16.

Regardless, the requested relief appears unnecessary. By filing a motion to

stay the mandate, Apple has achieved its goal of deferring the mandate’s issuance.

When a motion to stay a mandate is filed, the Federal Rules provide that the

mandate will not issue until after “entry of an order denying a . . . motion for stay

of the mandate.” Fed. R. App. P. 41(b). Accordingly, this Court may proceed to

decide Apple’s motion for leave to file a successive rehearing petition. If that is

denied, the motion to stay the mandate may be denied as well. Consequently,

14
Case: 18-1197 Document: 103 Page: 24 Filed: 08/19/2019

VirnetX does not oppose this Court reserving decision on this motion to stay the

mandate while it considers Apple’s motion to vacate the denial of rehearing and for

leave to file a successive petition for rehearing. The Court should deny that motion

promptly and issue the mandate immediately thereafter.

CONCLUSION

Apple’s motion to stay the mandate should be denied, and the mandate

should issue forthwith.

15
Case: 18-1197 Document: 103 Page: 25 Filed: 08/19/2019

August 19, 2019 Respectfully submitted,

/s/ Jeffrey A. Lamken


Donald Urrabazo Jeffrey A. Lamken
URRABAZO LAW, P.C. Counsel of Record
2029 Century Park East Michael G. Pattillo, Jr.
Suite 1400 Rayiner I. Hashem
Los Angeles, CA 90067 James A. Barta
(310) 388-9099 (telephone) MOLOLAMKEN LLP
(310) 388-9088 (fax) The Watergate, Suite 660
600 New Hampshire Avenue, N.W.
Counsel for Leidos, Inc. Washington, D.C. 20037
(202) 556-2000 (telephone)
(202) 556-2001 (fax)
jlamken@mololamken.com

Allison M. Gorsuch
MOLOLAMKEN LLP
300 N. LaSalle St.
Chicago, IL 60654
(312) 450-6700 (telephone)
(312) 450-6701 (fax)

Bradley Wayne Caldwell


Jason Dodd Cassady
John Austin Curry
CALDWELL CASSADY & CURRY
2101 Cedar Springs Road
Suite 1000
Dallas, TX 75201
(214) 888-4848 (telephone)
(214) 888-4849 (fax)

Counsel for VirnetX Inc.


Case: 18-1197 Document: 103 Page: 26 Filed: 08/19/2019

CERTIFICATE OF SERVICE
I certify that today, August 19, 2019, I caused the foregoing document to be

electronically filed with the Clerk of the Court for the U.S. Court of Appeals for

the Federal Circuit using the appellate CM/ECF system. All participants in the

case are registered CM/ECF users and will be served by the appellate CM/ECF

system.

August 19, 2019 /s/ Jeffrey A. Lamken


Case: 18-1197 Document: 103 Page: 27 Filed: 08/19/2019

CERTIFICATE OF COMPLIANCE
1. This document complies with the type-volume limitation of Fed. R. App. P.

27(d)(2)(A) because this document contains 3,543 words, excluding the

parts exempted by Fed. R. App. P. 27(d)(2) and Fed. R. App. P. 27(a)(2)(B).

2. This document complies with the typeface requirements of Fed. R. App. P.

32(a)(5) and the type style requirements of Fed. R. App. P. 32(a)(6) because

this document has been prepared in a proportionally spaced typeface using

Microsoft Word in Times New Roman 14 point font.

August 19, 2019 /s/ Jeffrey A. Lamken

Anda mungkin juga menyukai